Hematology

VEXAS

Questions discussed in this category

For patients with VEXAS syndrome and good response to azacitidine, what duration of therapy do you consider?

How do you decide to trial a patient off treatment? When do you consider spacing therapy and at what frequency?

1 Answer available

Which other agent would you consider for a patient with VEXAS who has failed methotrexate, multiple TNF inhibitors, Tocilizumab, and Ruxolitinib?

1 Answer available

Papers discussed in this category

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2022 Oct 17

VEXAS Syndrome-A Review of Pathophysiology, Presentation, and Prognosis.

Blood, 2022 Aug 25

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.

Annals of the rheumatic diseases, 2024 Sep 30

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.

Related Topics in Hematology